Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

127
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
127
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

258
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
258
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer Therapies02:49

Cancer Therapies

8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HORoSCOPE: Decoding human centromere architecture from short reads using <i>k</i> -mer signatures.

bioRxiv : the preprint server for biology·2026
Same author

Recurrent DNA break clusters drive replication-stress-induced copy number variants and genome diversification.

Nature communications·2026
Same author

Population differences of chromosome 22q11.2 duplication structure predispose differentially to microdeletion and inversion.

Nature communications·2026
Same author

A snapshot of the earliest stages of hepatocellular carcinoma.

Cancer cell·2026
Same author

Efficient protein structure generation with sparse denoising models.

Nature machine intelligence·2025
Same author

Origins of chromosome instability unveiled by coupled imaging and genomics.

Nature·2025
Same journal

Algorithm-hardware co-design of neuromorphic networks with dual memory pathways.

Nature machine intelligence·2026
Same journal

Plagiarism in the Age of Generative Artificial Intelligence: The advent of generative artificial intelligence (GenAI) tools is challenging the scientific community's understanding of the meaning and significance of plagiarism. A new definition of research misconduct is needed that specifically addresses the use of GenAI writing tools.

Nature machine intelligence·2026
Same journal

Platonic representation of foundation machine learning interatomic potentials.

Nature machine intelligence·2026
Same journal

Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation.

Nature machine intelligence·2026
Same journal

A generative artificial intelligence approach for peptide antibiotic optimization.

Nature machine intelligence·2026
Same journal

LLMs displaying less cognitive bias are not necessarily better decision makers.

Nature machine intelligence·2026
See all related articles

Related Experiment Video

Updated: Sep 14, 2025

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

229

Integrating multimodal cancer data using deep latent variable path modelling.

Alex Ing1, Alvaro Andrades1, Marco Raffaele Cosenza1

  • 1Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.

Nature Machine Intelligence
|July 25, 2025
PubMed
Summary
This summary is machine-generated.

We developed deep latent variable path modeling to integrate complex cancer data, outperforming traditional methods. This approach enhances understanding of cancer pathology by revealing associations across diverse data types.

Keywords:
Breast cancerComputer scienceData integrationMachine learning

More Related Videos

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.5K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Related Experiment Videos

Last Updated: Sep 14, 2025

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

229
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.5K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Cancer research

Background:

  • Cancer pathology is complex, involving genetic, microscopic, and macroscopic features.
  • Integrating diverse data types (imaging, omics) for a holistic understanding of cancer remains a challenge.

Purpose of the Study:

  • To introduce deep latent variable path modeling (DLVP) for integrating multi-omics and histologic data in cancer research.
  • To demonstrate DLVP's capability in mapping complex relationships within cancer pathology.

Main Methods:

  • Developed DLVP, combining deep learning and path modeling to identify interdependencies in complex systems.
  • Trained DLVP on The Cancer Genome Atlas (TCGA) breast cancer data, including single-nucleotide variant, methylation, microRNA, RNA sequencing, and histology.
  • Applied DLVP to stratify single-cell data, identify synthetic lethal interactions, and detect histologic-transcriptional associations.

Main Results:

  • DLVP demonstrated superior performance in mapping associations between diverse data types compared to classical path modeling.
  • Successfully applied DLVP to analyze single-cell, CRISPR-Cas9 screen, and spatial transcriptomic data.
  • The model provides a unified framework for interpreting results from various data modalities.

Conclusions:

  • DLVP offers a powerful new method for integrative analysis of multi-modal cancer data.
  • This approach facilitates a more comprehensive understanding of cancer pathology and disease mechanisms.
  • DLVP has broad applicability across various cancer research data types and applications.